{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:26:52Z","timestamp":1771000012038,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12348-019-0179-6","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T12:02:50Z","timestamp":1563537770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of vitreomacular adhesion on the treatment outcomes in the STOP-Uveitis clinical trial for non-infectious uveitis"],"prefix":"10.1186","volume":"9","author":[{"name":"for the STOP-Uveitis Investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam V.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Sohail","family":"Halim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubbia","family":"Afridi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ali","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samendra","family":"Karkhur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Vigil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selen","family":"Karabekirogullari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan Dong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana V.","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0104-6284","authenticated-orcid":false,"given":"Yasir J.","family":"Sepah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,19]]},"reference":[{"key":"179_CR1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.5301\/ejo.5000278","volume":"23","author":"E Miserocchi","year":"2013","unstructured":"Miserocchi E, Fogliato G, Modorati G, Bandello F (2013) Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol 23:705\u2013717","journal-title":"Eur J Ophthalmol"},{"key":"179_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2174\/1566524015666150731103847","volume":"15","author":"MA Sadiq","year":"2015","unstructured":"Sadiq MA, Agarwal A, Hassan M, Afridi R, Sarwar S, Soliman MK, Do DV, Nguyen QD (2015) Therapies in development for non-infectious uveitis. Curr Mol Med 15:565\u2013577","journal-title":"Curr Mol Med"},{"key":"179_CR3","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.humimm.2013.06.036","volume":"74","author":"EH Kang","year":"2013","unstructured":"Kang EH, Park JW, Park C, Yu HG, Lee EB, Park MH, Song YW (2013) Genetic and non-genetic factors affecting the visual outcome of ocular Behcet\u2019s disease. Hum Immunol 74:1363\u20131367","journal-title":"Hum Immunol"},{"key":"179_CR4","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.ajo.2015.09.017","volume":"160","author":"JH Kempen","year":"2015","unstructured":"Kempen JH, Van Natta ML, Altaweel MM, Dunn JP, Jabs DA, Lightman SL, Thorne JE, Holbrook JT (2015) Factors predicting visual acuity outcome in intermediate, posterior, and panuveitis: the Multicenter Uveitis Steroid Treatment (MUST) trial. Am J Ophthalmol 160:1133\u20131141.e1139","journal-title":"Am J Ophthalmol"},{"key":"179_CR5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.ajo.2007.12.032","volume":"145","author":"JE Thorne","year":"2008","unstructured":"Thorne JE, Daniel E, Jabs DA, Kedhar SR, Peters GB, Dunn JP (2008) Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis. Am J Ophthalmol 145:841\u2013846","journal-title":"Am J Ophthalmol"},{"key":"179_CR6","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1016\/j.ophtha.2013.07.042","volume":"120","author":"JS Duker","year":"2013","unstructured":"Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, Sadda SR, Sebag J, Spaide RF, Stalmans P (2013) The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120:2611\u20132619","journal-title":"Ophthalmology"},{"key":"179_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ophtha.2015.09.032","volume":"123","author":"MA Sadiq","year":"2016","unstructured":"Sadiq MA, Soliman MK, Sarwar S, Agarwal A, Hanout M, Demirel S, Rentiya ZS, Khan W, Do DV, Nguyen QD, Sepah YJ (2016) Effect of vitreomacular adhesion on treatment outcomes in the ranibizumab for edema of the macula in diabetes (READ-3) study. Ophthalmology 123:324\u2013329","journal-title":"Ophthalmology"},{"key":"179_CR8","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/bjophthalmol-2017-310155","volume":"101","author":"P Xie","year":"2017","unstructured":"Xie P, Zheng X, Yu Y, Ye X, Hu Z, Yuan D, Liu Q (2017) Vitreomacular adhesion or vitreomacular traction may affect antivascular endothelium growth factor treatment for neovascular age-related macular degeneration. Br J Ophthalmol 101:1003\u20131010","journal-title":"Br J Ophthalmol"},{"key":"179_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ophtha.2010.04.015","volume":"118","author":"SJ Lee","year":"2011","unstructured":"Lee SJ, Koh HJ (2011) Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration. Ophthalmology 118:101\u2013110","journal-title":"Ophthalmology"},{"key":"179_CR10","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2147\/OPTH.S141779","volume":"11","author":"H Suzuki","year":"2017","unstructured":"Suzuki H, Morishita S, Kohmoto R, Fukumoto M, Sato T, Kida T, Ueki M, Oku H, Nakamura K, Ikeda T (2017) The effect of vitreomacular adhesion in exudative age-related macular degeneration on the results of ranibizumab intravitreal injection. Clin Ophthalmol 11:1471\u20131475","journal-title":"Clin Ophthalmol"},{"key":"179_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/IAE.0b013e318295f72e","volume":"34","author":"GO Uney","year":"2014","unstructured":"Uney GO, Unlu N, Acar MA, Hazirolan D, Altiparmak UE, Yalniz-Akkaya Z, Ornek F (2014) Role of posterior vitreous detachment on outcome of anti-vascular endothelial growth factor treatment in age-related macular degeneration. Retina 34:32\u201337","journal-title":"Retina"},{"key":"179_CR12","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.2147\/OPTH.S146019","volume":"11","author":"AN Kulikov","year":"2017","unstructured":"Kulikov AN, Sosnovskii SV, Berezin RD, Maltsev DS, Oskanov DH, Gribanov NA (2017) Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study. Clin Ophthalmol 11:1995\u20132002","journal-title":"Clin Ophthalmol"},{"key":"179_CR13","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1111\/aos.12699","volume":"93","author":"MR Munk","year":"2015","unstructured":"Munk MR, Ram R, Rademaker A, Liu D, Setlur V, Chau F, Schmidt-Erfurth U, Goldstein DA (2015) Influence of the vitreomacular interface on the efficacy of intravitreal therapy for uveitis-associated cystoid macular oedema. Acta Ophthalmol 93:e561\u2013e567","journal-title":"Acta Ophthalmol"},{"key":"179_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ajo.2017.08.019","volume":"183","author":"YJ Sepah","year":"2017","unstructured":"Sepah YJ, Sadiq MA, Chu DS, Dacey M, Gallemore R, Dayani P, Hanout M, Hassan M, Afridi R, Agarwal A et al (2017) Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients With Noninfectious Uveitis. Am J Ophthalmol 183:71\u201380","journal-title":"Am J Ophthalmol"},{"key":"179_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2147\/OPTH.S97722","volume":"10","author":"W Stevenson","year":"2016","unstructured":"Stevenson W, Prospero Ponce CM, Agarwal DR, Gelman R, Christoforidis JB (2016) Epiretinal membrane: optical coherence tomography-based diagnosis and classification. Clin Ophthalmol 10:527\u2013534","journal-title":"Clin Ophthalmol"},{"key":"179_CR16","doi-asserted-by":"publisher","first-page":"853728","DOI":"10.1155\/2015\/853728","volume":"2015","author":"P Tortorella","year":"2015","unstructured":"Tortorella P, D'Ambrosio E, Iannetti L, De Marco F, La Cava M (2015) Correlation between visual acuity, inner segment\/outer segment junction, and cone outer segment tips line integrity in uveitic macular edema. Biomed Res Int 2015:853728","journal-title":"Biomed Res Int"},{"key":"179_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1136\/bjophthalmol-2011-301418","volume":"97","author":"S Ito","year":"2013","unstructured":"Ito S, Miyamoto N, Ishida K, Kurimoto Y (2013) Association between external limiting membrane status and visual acuity in diabetic macular oedema. Br J Ophthalmol 97:228\u2013232","journal-title":"Br J Ophthalmol"},{"key":"179_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ajo.2005.03.045","volume":"140","author":"U Stolba","year":"2005","unstructured":"Stolba U, Binder S, Gruber D, Krebs I, Aggermann T, Neumaier B (2005) Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol 140:295\u2013301","journal-title":"Am J Ophthalmol"},{"key":"179_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.survophthal.2005.12.001","volume":"51","author":"LA Donoso","year":"2006","unstructured":"Donoso LA, Kim D, Frost A, Callahan A, Hageman G (2006) The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 51:137\u2013152","journal-title":"Surv Ophthalmol"},{"key":"179_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00006982-200502000-00001","volume":"25","author":"AP Adamis","year":"2005","unstructured":"Adamis AP, Shima DT (2005) The role of vascular endothelial growth factor in ocular health and disease. Retina 25:111\u2013118","journal-title":"Retina"},{"key":"179_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00417-008-0980-7","volume":"247","author":"E Stefansson","year":"2009","unstructured":"Stefansson E (2009) Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol 247:147\u2013163","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-019-0179-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12348-019-0179-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-019-0179-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T23:06:03Z","timestamp":1595027163000},"score":1,"resource":{"primary":{"URL":"https:\/\/joii-journal.springeropen.com\/articles\/10.1186\/s12348-019-0179-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,19]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["179"],"URL":"https:\/\/doi.org\/10.1186\/s12348-019-0179-6","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,19]]},"assertion":[{"value":"10 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The STOP-Uveitis clinical trial was conducted in compliance with the US Code of Federal Regulations Title 21, the Declaration of Helsinki, and the Harmonized Tripartite Guidelines for Good Clinical Practice (1996). The study was approved by local institutional review boards for selected sites and by a central review board for others. Signed informed consent was obtained from all the participants of the study<b>.<\/b>","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"YJS has received research support from Astellas, Genentech, and Optovue and serves on the Scientific Advisory Board for Genentech\/Roche, Optos, and Regeneron.QDN is a recipient of a Physician Scientist Award from Research to Prevent Blindness, New York, NY, and serves on the Scientific Advisory Board for AbbVie, Bayer, Genentech, Regeneron, and Santen, among others. QDN also chaired the Steering Committee for the RISE and RIDE studies and was on the Steering Committee for the VISTA Study, and other studies sponsored by Genentech and Regeneron.DVD is a consultant for Allergan, Genentech, Regeneron, and Santen and she has received research support from Genentech, Regeneron, and Santen. DVD also chaired the Steering Committee for the VISTA Study.The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}